GLP-1
-
healthEarly Research Suggests Weight Loss Drugs Like Ozempic Could Be Longevity Drugs
Initial studies on GLP-1 medications indicate they may slow biological aging and combat diseases of aging, though experts warn the data is preliminary and not for the metabolically healthy.
-
healthUK Public Divided on Weight Loss Drugs: Health vs. Long-Term Risks
New YouGov survey reveals the British public is evenly split on the value of weight loss medications, with safety and lifestyle concerns dominating the debate.
-
healthHow a 1922 Rescue Mission Explains Ozempic’s $969 US vs. €59 German Price
The identical semaglutide pen costs sixteen times more in the US than in Germany. The price gap traces back to a Canadian discovery, a Danish foundation, and America's unique pharmacy-benefit system.
-
healthFrom Lizard Venom to National Phenomenon: How GLP-1 Drugs Reached One in Eight Americans
A Bronx endocrinologist’s discovery in Gila monster saliva, initially rejected by the government, spawned a class of drugs now used by roughly one in eight U.S. adults for weight loss and diabetes.
-
healthWhy Ozempic Fails for Some Patients: Stanford Uncovers a Genetic Resistance
New research from Stanford indicates that a specific genetic variant in the PAM enzyme causes biological resistance to GLP-1 drugs like Ozempic, impacting blood sugar control.
-
healthMedicare Launches Pilot Program for Weight-Loss Drugs Wegovy, Zepbound
A new Medicare bridge program will cover popular weight-loss medications like Wegovy and Zepbound for eligible older adults starting July 1st, with a $50 monthly copay.
-
healthHealth Canada Approves Zepbound for Sleep Apnea in Obese Adults
The weight-loss drug becomes the first GLP-1 medication authorized in Canada to treat obstructive sleep apnea linked to obesity, offering a new option alongside CPAP therapy.
-
healthGLP-1 Medications Linked to Improved Male Fertility and Testosterone Levels
New research presented at ENDO 2026 suggests GLP-1 weight-loss drugs may improve testosterone and sperm quality in obese men, offering a fertility-preserving alternative to traditional hormone replacement therapy.